Hypoxia stimulates osteoclast formation from human peripheral blood

Area of Science:

• Cell Biology
• Physiology
• Pathology

Background:

• Pathological bone destruction frequently occurs in low oxygen environments, such as tumors, inflammation, infections, fractures, and elderly fatty marrow.
• Osteoclasts are the primary cells responsible for bone resorption.
• Understanding the role of oxygen tension in osteoclastogenesis is crucial for addressing bone loss conditions.

Purpose of the Study:

• To investigate the effect of varying oxygen tension (pO(2)) on the formation and activity of human osteoclasts.
• To elucidate the molecular mechanisms underlying hypoxia-induced osteoclastogenesis.

Main Methods:

• Culturing normal human peripheral blood mononuclear cells (hPBMCs) for 14 days on ivory discs under different oxygen conditions (1-2% O(2) vs. 20% O(2)).
• Quantifying osteoclast number, nuclei per osteoclast, and resorption pit formation.
• Analyzing the expression of hypoxia-inducible factors (HIF1alpha, HIF2alpha), vascular endothelial growth factor (VEGF), and interleukin-6 (IL-6).

Main Results:

• Hypoxia (1-2% O(2)) led to a threefold increase in osteoclast formation compared to normoxia (20% O(2)).
• Osteoclasts formed under hypoxia contained twice the number of nuclei, resulting in up to a tenfold increase in bone resorption.
• Hypoxia induced stabilization of HIF1alpha and HIF2alpha, and upregulated VEGF and IL-6 expression in hPBMCs.

Conclusions:

• Hypoxia significantly promotes osteoclast formation and bone resorption.
• Stabilization of HIFs and upregulation of VEGF and IL-6 are key molecular events mediating hypoxia's effect on osteoclasts.
• This provides a mechanism explaining bone loss in hypoxic pathological conditions and suggests potential therapeutic targets.